Viewing Study NCT03040635


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-01-05 @ 6:09 PM
Study NCT ID: NCT03040635
Status: COMPLETED
Last Update Posted: 2018-10-04
First Post: 2017-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) in Healthy Japanese Participants
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module